We establish that in TNBC tumors from obese mice, GPX4-mediated redox defense is a targetable vulnerability, and that GPX4 is a powerful regulator of treatment response in our metM-Wntlung model of TNBC and obesity. The gene discussed is GPX4; the disease is obesity due to melanocortin 4 receptor deficiency.